Creative Biolabs Boosts Antibody Discovery Against Glycan-Shielded Viruses

Creative Biolabs boosts anti-glycan antibody discovery, targeting glycan-shielded viruses like Ebola and Zika to overcome immune evasion and accelerate antiviral therapeutic development.